EarlySense provides contact-free, continuous monitoring solutions for the medical and consumer digital health markets. EarlySense's patented sensor and advanced algorithms monitor and analyze cardiac, respiratory, sleep and motion parameters. Used in hospitals and healthcare facilities worldwide, EarlySense assists clinicians in early detection of patient deterioration, helping to prevent adverse events, including code blues, preventable ICU transfers, patient falls and pressure ulcers. Additionally, the company's myEarlySense smart home-compatible consumer solution brings hospital-proven technology to the home, providing valuable data regarding wellness and sleep. On February 1st, 2021 EarlySense was acquired by Hillrom.
Expert Collections containing EarlySense
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
EarlySense is included in 3 Expert Collections, including Conference Exhibitors.
Companies that will be exhibiting at CES 2018
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.
EarlySense has filed 42 patents.
Engine technology, Engine components, Medical tests, Diabetes, Sensors
Engine technology, Engine components, Medical tests, Diabetes, Sensors
Latest EarlySense News
Sep 18, 2023
Country scope Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States Report coverage Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends Developments in Healthcare Infrastructures and Growth Strategies by Smart Hospital Bed Providers Boost Smart Hospital Beds Market Growth: The latest innovations or upgrades in products encourage healthcare facilities to adopt new technologies. Governments are putting efforts into enhancing their healthcare infrastructure by providing funds to build hospitals that are equipped with state-of-the-art technologies. A few of the latest developments by governments and companies in the smart hospital beds market are mentioned below. • In February 2023, Stryker launched SmartMedic, the first ICU bed upgrade platform introduced in India, to enhance patient care and caregivers’ safety. • In August 2022, Dozee partnered with Midmark India, one of the largest hospital bed manufacturers in South Asia, and launched a connected bed platform for non-ICU settings. The AI-powered contactless sensor from Dozee is integrated into the bed and is placed under the mattress to detect a patient's vital signs, including heart and respiration rates, temperature, oxygen saturation, and electrocardiogram (ECG). Additionally, it features an early warning system that warns healthcare professionals so they can act quickly. • In February 2021, Hillrom acquired contact-free continuous monitoring technology from EarlySense for a value of US$ 30 million to strengthen its Centrella Smart+Bed designed to monitor heart and respiratory rates that are above 100 units per minute. The enablement by EarlySense technology allows Centrella Smart beds to send potential alerts to clinicians about the deterioration of patients’ health. • In October 2020, the President of the UK affirmed to provide funding to 40 hospitals under the Health Infrastructure Plan (HIP) in the country. The President assigned funds of US$ 3 billion (£3.7 billion) for the first 40 hospitals to be built by 2030. In addition, 8 more schemes were committed to fund 48 more hospitals by 2030. • In October 2020, Stryker launched its ProCurity, a fully wireless hospital bed. ProCurity is a smart bed designed ergonomically with a height of 11.5 inches to prevent or reduce in-hospital patient falls at all acuity levels. The beds have easy-to-use touchscreens and bed monitoring systems. The ProCurity smart beds are meant to improve the safety of patients, enhance the work efficiency of nursing staff, and lower the operating costs of hospitals. In February 2021, Stryker launched the safe, smart, and scalable ProCuity Bed Series, which is made available in 70 countries worldwide. Global Smart Hospital Beds Market: Segmental Overview The “Global Smart Hospital Beds Market” is segmented based on patient weight, offering, application, end user, and geography. The market, by patient weight, is further segmented into less than 70 lb, 70–150 lb, 150–400 lb, 400–500 lb, and greater than 500 lb. The 400 to 500 lb segment held the largest market share in 2022, and the same segment is anticipated to register the highest CAGR during the forecast period. Smart hospital beds with 400–500 lb weight capacity are modern nursing beds highly appropriate for recycling due to their adjustability features. The Advantage ReadyWide Bed Model offered by Span-America Medical Systems Inc. comes with Integrated Expansion and smart technologies, which enable hospital beds comprised advanced clinical and resident positioning. The product delivers an expanded safe working load (SWL) of 650 lb with the influx of features of the Standard (500 lb SWL) model. The smart hospital beds market, by offering, is segmented into products & accessories, software & solutions, and services. The products & accessories segment held the largest market share in 2022. The services segment is anticipated to register the highest CAGR during the forecast period. Technological advancements are a major force that supports the launch of new and updated smart hospital beds enabled with highly developed embedded-control functions and interactivity. These beds are a comprehensive synthesis of three things: integrated solutions for patient care, assistance, and monitoring. Smart hospital bed products include wireless sensor networks (WSNs), offering a seamless and efficient solution to avoid the generation of bedsores in motion-impaired patients. Simple software (apps) with electronic intelligence has transformed smart hospital bed products into highly networked appliances. Order a Copy of this Report at https://www.theinsightpartners.com/buy/TIPRE00011950 Based on end user, the smart hospital beds market is divided into hospitals, clinics & nursing homes, ambulatory surgical centers, medical laboratories, long-term care centers, and others. The hospitals segment held the largest market share in 2022. The clinics & nursing homes segment is anticipated to register the highest CAGR during the forecast period. Hospitals are complex organizations and institutes that provide healthcare to people by using specialized scientific equipment and a team of trained staff educated on the problems of modern medical science. Most surgeries are performed in hospitals and clinics as these facilities offer continuous patient care and monitoring. The rising prevalence of chronic diseases, growing geriatric population, and increasing number of hospitals and clinics primarily contribute to the growth of hospitals and clinics. The US is the largest market for smart hospital beds in North America. The growth of the smart hospital beds market in the US is majorly driven by the increasing prevalence of chronic diseases such as diabetes and cancer, and lifestyle diseases such as obesity; rapid growth of the geriatric population; longer hospital stays after critical surgery procedures; availability of technologically advanced smart hospital beds; and favorable reimbursement policies. Patients suffering from chronic diseases such as cancer, cardiovascular diseases, immune deficiencies, multiple sclerosis, and rheumatoid arthritis need long-term monitoring and treatment. As a result, they may need to stay in hospitals for long periods. Smart beds gather information on the health status of patients and aid in statistical analysis. This results in increased efficiency and accurate diagnostics for healthcare providers and medical professionals while paving the way to reduce the number of hospital readmissions. Smart beds can create a network of connected devices, mechanical and digital gear, or people with unique identifiers, and they can rapidly transmit data to designated systems. Global Smart Hospital Beds Market: Competitive Landscape Hill-Rom Holdings Inc, Stryker Corp, B. Braun SE, Arjo AB, Invacare Corp, Paramount Bed Co Ltd, Linet Spl, Malvestio SpA, Stiegelmeyer GmbH & Co. KG, and Umano Medical Inc. are among the leading companies operating in the smart hospitals bed market. These players focus on expanding and diversifying their market presence and acquiring a novel customer base, tapping prevailing business opportunities in the smart hospital bed market. Global Smart Hospital Beds Market - Key Industry Dynamics: Drivers Upsurge in Geriatric Population Recent Developments: In March 2023, Stryker announced the launch of the SmartMedic platform at the 29th Annual Conference of the Indian Society of Critical Care Medicine in Indore. SmartMedic is a patient care platform that enhances the capabilities of existing ICU beds in hospitals. In November 2022, Linet Group acquired Pegasus Health Group, Sidney, to strengthen its presence in the Australian market by offering its full range of premium services to customers in New South Wales. LINET Group thus continues to widen its global sales network through such expansion strategies. Australia is an increasingly important market for the Linet Group due to its high-standard healthcare sector, which is considered quite comparable to the US. Go through further research published by The Insight Partners:
EarlySense Frequently Asked Questions (FAQ)
When was EarlySense founded?
EarlySense was founded in 2004.
Where is EarlySense's headquarters?
EarlySense's headquarters is located at Derech Ze'ev Jabotinsky 7, Ramat Gan.
What is EarlySense's latest funding round?
EarlySense's latest funding round is Acquired.
How much did EarlySense raise?
EarlySense raised a total of $127M.
Who are the investors of EarlySense?
Investors of EarlySense include Hillrom, Pitango Venture Capital, JK&B Capital, Israel Innovation Fund, Argos Capital and 16 more.
Who are EarlySense's competitors?
Competitors of EarlySense include MyelinH, Inicare, Acelity, RF Surgical Systems, Invivodata and 7 more.
Compare EarlySense to Competitors
After two years of development, testing and continuous improvement and trials at various hospitals, INFLO Infusion Flow Rate Monitor was introduced. INFLO is a microprocessor-controlled device with high level of accuracy, which can be used to monitor the infusion flow rate. Its low cost and low operating expenses as well as long life cycle aims to make it an alternative to the expensive infusion monitoring devices and aims to give accuracy and safety with inexpensive infusion sets.
findtheDOT designs and develops technology to match medications to patients and physician orders. The Company's printed code mark and portable, wireless code reader provide a practical means of validating medications at the patient bedside.
VivoMetrics provides continuous ambulatory monitoring products and services for the collection, analysis, and reporting of patient specific physiologic data serving pharmaceutical, biotechnology, and device companies.
SonoMedix is developing a device to monitor blood coagulation and hemostatic status, using NanoAcoustic Blood Analyzer (NABA) technology licensed from Drexel University. SonoMedix is developing a working NABA-based prototype of a device to be used at home to measure the prothombin time, a measure of blood coagulation, in patients taking the anticoagulant drug, warfarin (Coumadin ). The device will allow the patients who need to perform this testing to use a smaller amount of blood than currently marketed devices, which will allow them to obtain blood from sites other than fingers, reducing the pain of obtaining the sample. The small sample size is currently being validated.
Binx Health is a healthcare company focused on point-of-care molecular diagnostics. The company offers diagnostic solutions that enable healthcare providers to deliver timely, high-quality care, including a testing platform for the diagnosis and treatment of chlamydia and gonorrhea infections. Binx Health primarily serves the healthcare industry. Binx Health was formerly known as Atlas Genetics. It was founded in 2005 and is based in Cambridge, Massachusetts.
NIR Diagnostics is developing a diagnostic device to quantitatively assess the progress of the wound healing process. Per the company, the device has the potential to be a more accurate, more rapid, and less expensive method of wound assessment compared to those currently on the market.